Search - tctmd.com

Displaying 1 - 20 of 163

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2025

Michael O'Riordan

September 30, 2025

News Conference News ESC 2025

Renewed Questions About Safety of Paclitaxel Devices in PAD: SWEDEPAD

L.A. McKeown

September 05, 2025

News Daily News

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

L.A. McKeown

June 12, 2025

News Conference News CX Symposium 2025

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

L.A. McKeown

April 23, 2025

News Daily News ACC 2025

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

L.A. McKeown

March 29, 2025

News Daily News

Survey Calls Out Implicit Bias in Peripheral Vascular Care

L.A. McKeown

February 28, 2025

News Conference News TCT 2024

PAD Patients’ Views on Decisions and Outcomes Hinge on Sex, Race/Ethnicity: ELEGANCE

L.A. McKeown

November 04, 2024

News Conference News TCT 2024

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

L.A. McKeown

October 29, 2024

Presentation TCT 2024

TCT 30: Comparative Outcomes of Non-Stent Below-the-Knee Peripheral Artery Interventions in Critical Limb Threatening Ischemia vs Intermittent Claudication From the XLPAD Registry

Presenter: Minseob Jeong

October 27, 2024

News Daily News

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

L.A. McKeown

May 17, 2024

News Daily News

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

L.A. McKeown

July 11, 2023

News Conference News ISET 2023

Advent of Outpatient Endovascular Care Part of a ‘Sea Change’ in Medicine

Caitlin E. Cox

January 26, 2023

News Daily News

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

L.A. McKeown

January 24, 2023

News Conference News ISET 2023

BioMimics 3D Stent Holds Up Well at 3 Years in Complex PAD Lesions

Caitlin E. Cox

January 20, 2023

News Conference News

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

L.A. McKeown

November 18, 2022

News Daily News

Worse Complications After PVI in Women Highlight Research Gaps

L.A. McKeown

August 16, 2022

News Daily News

Comorbidities May Drive PAD Procedural Outcomes in Black Patients

L.A. McKeown

June 23, 2022

News Daily News

MOSAIC: Home Intervention Boosts Walking Time in PAD Patients

L.A. McKeown

April 15, 2022

News Conference News ACC 2022

Second-Generation Chocolate Touch DCB Bests Lutonix for Patency in PAD

L.A. McKeown

April 04, 2022

News Daily News

Postmarketing Studies of CV Devices Still Lacking in the US

Caitlin E. Cox

March 17, 2022

Advertisement

TCTMD’s Top 10 Most Popular Stories for September 2025

Renewed Questions About Safety of Paclitaxel Devices in PAD: SWEDEPAD

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

Survey Calls Out Implicit Bias in Peripheral Vascular Care

PAD Patients’ Views on Decisions and Outcomes Hinge on Sex, Race/Ethnicity: ELEGANCE

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

TCT 30: Comparative Outcomes of Non-Stent Below-the-Knee Peripheral Artery Interventions in Critical Limb Threatening Ischemia vs Intermittent Claudication From the XLPAD Registry

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

Advent of Outpatient Endovascular Care Part of a ‘Sea Change’ in Medicine

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

BioMimics 3D Stent Holds Up Well at 3 Years in Complex PAD Lesions

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

Worse Complications After PVI in Women Highlight Research Gaps

Comorbidities May Drive PAD Procedural Outcomes in Black Patients

MOSAIC: Home Intervention Boosts Walking Time in PAD Patients

Second-Generation Chocolate Touch DCB Bests Lutonix for Patency in PAD

Postmarketing Studies of CV Devices Still Lacking in the US

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content